[1]彭 金,肖三法,袁海花.血容量监测联合米多君治疗维持性血液透析低血压患者的临床研究[J].医学信息,2021,34(23):50-53.[doi:10.3969/j.issn.1006-1959.2021.23.014]
　PENG Jin,XIAO San-fa,YUAN Hai-hua.Clinical Study of Blood Volume Monitoring Combined with Midodrine in Patients with Maintenance Hemodialysis Hypotension[J].Medical Information,2021,34(23):50-53.[doi:10.3969/j.issn.1006-1959.2021.23.014]
点击复制

血容量监测联合米多君治疗维持性血液透析低血压患者的临床研究()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
34卷
期数:
2021年23期
页码:
50-53
栏目:
论著
出版日期:
2021-12-01

文章信息/Info

Title:
Clinical Study of Blood Volume Monitoring Combined with Midodrine in Patients with Maintenance Hemodialysis Hypotension
文章编号:
1006-1959（2021）23-0050-04
作者:
彭 金; 肖三法; 袁海花
（于都县人民医院肾内科，江西 于都 342300）
Author(s):
PENG Jin; XIAO San-fa; YUAN Hai-hua
(Department of Nephrology,Yudu County People’s Hospital,Yudu 342300,Jiangxi,China)
关键词:
维持性血液透析; 低血压; 血容量监测; 米多君; 平均动脉压
Keywords:
Maintenance hemodialysis; Low blood pressure; Blood volume monitoring; Midojun; Mean arterial pressure
分类号:
R692
DOI:
10.3969/j.issn.1006-1959.2021.23.014
文献标志码:
A
摘要:
目的 研究血容量监测联合米多君治疗维持性血液透析低血压患者的临床效果。方法 选取2020年4月-2021年8月我院收治的60例维持性血液透析低血压患者，随机分为对照组与观察组，各30例。对照组采用米多君治疗，观察组应用血容量监测联合米多君治疗，比较两组临床疗效、平均动脉压、心率、透析过程中血压变化情况、透析中低血压（IDH）发生率及脱水量。结果 观察组治疗总有效率高于对照组（96.67% vs 80.00%），差异有统计学意义（P＜0.05）。透析2 h后，两组平均动脉压下降，心率升高，但观察组平均动脉压高于对照组，心率低于对照组，差异有统计学意义（P＜0.05）。透析过程中，两组收缩压、舒张压水平均有下降，但观察组高于对照组，透析后，两组收缩压、舒张压水平上升，观察组高于对照组，差异有统计学意义（P＜0.05）。观察组IDH发生率低于对照组（3.33% vs 23.33%），脱水量高于对照组，差异有统计学意义（P＜0.05）。结论 血容量监测联合米多君治疗维持性血液透析低血压，临床疗效确切，可维持透析中体征指标的稳定性，减少血压波动，降低透析中低血压的发生风险，保证脱水量。
Abstract:
Objective To study the clinical effect of blood volume monitoring combined with midodrine in the treatment of maintenance hemodialysis hypotension.Methods A total of 60 patients with maintenance hemodialysis hypotension admitted to our hospital from April 2020 to August 2021 were randomly divided into control group and observation group, with 30 cases in each group. The control group was treated with midodrine, and the observation group was treated with blood volume monitoring combined with midodrine. The clinical efficacy, mean arterial pressure, heart rate, blood pressure changes during dialysis, incidence of hypotension (IDH) during dialysis and dehydration were compared between the two groups.Results The total effective rate of the observation group was higher than that of the control group (96.67% vs 80.00%), and the difference was statistically significant (P<0.05). After 2 h of dialysis, the mean arterial pressure of the two groups decreased and the heart rate increased, but the mean arterial pressure of the observation group was higher than that of the control group, and the heart rate was lower than that of the control group, and the difference was statistically significant (P<0.05). During dialysis, the systolic and diastolic blood pressure levels of the two groups decreased, but the observation group was higher than the control group; after dialysis, the systolic and diastolic blood pressure levels of the two groups increased, and the observation group was higher than the control group, the difference was statistically significant (P<0.05). The incidence of IDH in the observation group was lower than that in the control group (3.33% vs 23.33%), and the dehydration rate was higher than that in the control group, the difference was statistically significant (P<0.05).Conclusion Blood volume monitoring combined with midojun in the treatment of maintenance hemodialysis hypotension has definite clinical efficacy, which can maintain the stability of signs in dialysis, reduce blood pressure fluctuations, reduce the risk of hypotension in dialysis, and ensure dehydration.

参考文献/References:

[1]潘璐璐,何颖雪,邵国建.维持性血液透析患者发生透析中低血压的相关危险因素分析[J].浙江医学,2019,41(22):2421-2423,2437.[2]Rodríguez-Chagolla J,Cartas-Rosado R,Lerma C,et al.Low-Intensity Intradialytic Exercise Attenuates the Relative Blood Volume Drop Due to Intravascular Volume Loss during Hemodiafiltration[J].Blood Purification,2021,50(2):180-187.[3]俞金海.维持性血液透析患者低血压发生现状及影响因素分析[J].基层医学论坛,2021,25(11):1522-1524.[4]王卫华,徐小溪.肾素-血管紧张素系统与维持性血液透析患者高血压发病机制的关系分析[J].吉林医学,2021,42(3):592-594.[5]何景芳,罗姗,李海涛.N末端脑钠肽前体联合在线血容量监测在维持性血液透析中的应用[J].实用临床医药杂志,2021,25(5):69-73.[6]夏红林.分析血液透析患者应用米多君联合可调钠透析对其并发症发生的影响[J].北方药学,2020,17(8):34-35.[7]Brunelli S,Cohen D,Marlowe G,et al.The Impact of Midodrine on Outcomes in Patients with Intradialytic Hypotension[J].American Journal of Nephrology,2018,48(5):381-388.[8]Miskulin DC,Weiner DE.Blood Pressure Management in Hemodialysis Patients: What We Know And What Questions Remain[J].Seminars in Dialysis,2017,30(3):203-212.[9]余金波,刘中华,沈波,等.透析中低血压对血液透析患者长期预后的影响[J].中华肾脏病杂志,2016,32(9):665-672.[10]周娜,燕玮.糖尿病肾病患者维持性血液透析中血压异常发生情况及影响因素[J].中国卫生工程学,2020,19(5):788-790.[11]陈雪兰,丘余良.维持性血液透析患者频发透析中低血压的相关因素分析[J].中国现代医生,2020,58(23):110-112,117.[12]刘瑞,李慧丽,张瑞.盐酸米多君联合低温透析防治血液透析中低血压疗效观察[J].实用医技杂志,2015,22(12):1328-1329.[13]Byun JI,Moon J,Kim DY,et al.Efficacy of single or combined midodrine and pyridostigmine in orthostatic hypotension[J].Neurology,2017,19(4):434-437.[14]丁婷,谢先顺,张筠,等.维持性血液透析患者透析相关性低血压的影响因素分析[J].中国卫生标准管理,2019,10(19):34-36.[15]姜振华,任玉卿,史官茂,等.维持性血液透析患者透析过程中发生有效血容量不足时血压波动特征及其与透析开始时血压的比较[J].中国综合临床,2020,36(1):40-45.[16]Keane DF,Raimann JG,Zhang H,et al.The time of onset of intradialytic hypotension during a hemodialysis session associates with clinical parameters and mortality[J].Kidney International,2021,99(6):1408-1417.[17]林秋燕,曹木根,梁文瑜.终末期肾病维持性血液透析患者透析时血压变异性的影响因素分析[J].临床合理用药杂志,2017,10(36):142-144.[18]尹懿,郑秀瑗,伦立德,等.维持性血液透析患者透析过程中细胞内外液变化规律[J].中国血液净化,2017,16(9):582-586.[19]董蓓晔,王汉清,马骏.维持性血液透析低血压患者在线血容量监测联合米多君治疗的应用研究[J].医药论坛杂志,2021,42(13):27-30.[20]巩楠,张学强,韩晶,等.在线血容量监测联合米多君治疗在维持性血液透析低血压病人中的临床观察[J].安徽医药,2019,23(2):360-363.[21]Koda Y,Aoike I.Prevention of Intradialytic Hypotension with Intermittent Back-Filtrate Infusion Haemodiafiltration: Insights into the Underlying Mechanism.[J].Blood Purification,2019,48(Suppl 1):1-6.[22]李媛媛,祝浩栋.透析中低血压的危险因素及其与患者死亡的相关性分析[J].中国医学前沿杂志(电子版),2019,11(12):106-109.[23]李梦甜,庄冰,陈静,等.维持性血液透析患者透析中低血压与人体成分的关系[J].现代生物医学进展,2021,21(11):2053-2056.[24]Ookawara S,Ito K,Uchida T,et al.Hemodialysis crossover study using a relative blood volume change-guided ultrafiltration control compared with standard hemodialysis: the BV-UFC study[J].Renal Replacement Therapy,2020,6(1):45.[25]覃世栈.维持性血液透析患者低血压发生调查及其危险因素分析[J].医学理论与实践,2020,33(14):2298-2300.

相似文献/References:

[1]祁亚轩.不同血液净化方式对维持性血液透析患者残余肾功能影响的临床护理观察[J].医学信息,2018,31(01):167.[doi:10.3969/j.issn.1006-1959.2018.01.066]
　QI Ya-xuan.Clinical Nursing Observation on the Influence of Different Blood Purification Methods on Residual Renal Function in Maintenance Hemodialysis Patients[J].Medical Information,2018,31(23):167.[doi:10.3969/j.issn.1006-1959.2018.01.066]
[2]肖一红.组合型人工肾技术预防血液透析中低血压的效果观察[J].医学信息,2018,31(03):185.[doi:10.3969/j.issn.1006-1959.2018.03.070]
　XIAO Yi-hong.Effect of Combined Artificial Renal Technique in Preventing Hypotension in Hemodialysis[J].Medical Information,2018,31(23):185.[doi:10.3969/j.issn.1006-1959.2018.03.070]
[3]易丽华.运动疗法配合护理干预对维持性血液透析患者 营养状况及生活质量的影响[J].医学信息,2018,31(16):175.[doi:10.3969/j.issn.1006-1959.2018.16.056]
　YI Li-hua.Effect of Exercise Therapy Combined with Nursing Intervention on Nutritional Status and Quality of Life in Maintenance Hemodialysis Patients[J].Medical Information,2018,31(23):175.[doi:10.3969/j.issn.1006-1959.2018.16.056]
[4]赵 立,褚海辰,梁永新.苯肾上腺素预输注防治老年人脊麻后低血压的临床研究[J].医学信息,2018,31(20):81.[doi:10.3969/j.issn.1006-1959.2018.20.023]
　ZHAO Li,CHU Hai-chen,LIANG Yong-xin.Clinical Study of Phenylephrine Pre-infusion for Prevention and Treatment of Hypotension after Spinal Anesthesia in the Elderly[J].Medical Information,2018,31(23):81.[doi:10.3969/j.issn.1006-1959.2018.20.023]
[5]刘 艳.三段式康复教育模式在维持性血液透析患者中的应用效果[J].医学信息,2019,32(20):190.[doi:10.3969/j.issn.1006-1959.2019.20.062]
　LIU Yan.Application Effect of Three-stage Rehabilitation Education Mode in Maintenance Hemodialysis Patients[J].Medical Information,2019,32(23):190.[doi:10.3969/j.issn.1006-1959.2019.20.062]
[6]丘宝珍.碳酸镧治疗维持性血液透析患者高磷血症的疗效[J].医学信息,2019,32(24):148.[doi:10.3969/j.issn.1006-1959.2019.24.053]
　QIU Bao-zhen.Effect of Lanthanum Carbonate on Hyperphosphatemia in Patients with Maintenance Hemodialysis[J].Medical Information,2019,32(23):148.[doi:10.3969/j.issn.1006-1959.2019.24.053]
[7]陈爱梅.不同维持性血液透析效果的糖尿病肾病患者营养评估及个性化饮食护理[J].医学信息,2019,32(24):177.[doi:10.3969/j.issn.1006-1959.2019.24.066]
　CHEN Ai-mei.Evaluation of Nutritional Status and Personalized Diet Nursing for Diabetic Nephropathy Patientswith Different Maintenance Hemodialysis Effects[J].Medical Information,2019,32(23):177.[doi:10.3969/j.issn.1006-1959.2019.24.066]
[8]金 鹏,周炳凤.去甲肾上腺素在心肌梗死合并低血压中的应用[J].医学信息,2020,33(07):57.[doi:10.3969/j.issn.1006-1959.2020.07.017]
　JIN Peng,ZHOU Bing-feng.Application of Norepinephrine in Myocardial Infarction with Hypotension[J].Medical Information,2020,33(23):57.[doi:10.3969/j.issn.1006-1959.2020.07.017]
[9]房 彩,孙蓓蓓,姚 博,等.KDQOL-SF量表评估社区血透中心维持性血液透析患者健康相关生活质量的意义[J].医学信息,2020,33(11):95.[doi:10.3969/j.issn.1006-1959.2020.11.027]
　FANG Cai,SUN Bei-bei,YAO Bo,et al.Significance of KDQOL-SF Scale to Evaluate the Health-related Quality of Life of Maintenance Hemodialysis Patients in Community Hemodialysis Centers[J].Medical Information,2020,33(23):95.[doi:10.3969/j.issn.1006-1959.2020.11.027]
[10]梁宏丽.基于Omaha系统的延续性护理模式对维持性血液透析患者行为依从性和钙磷代谢的影响[J].医学信息,2020,33(23):164.[doi:10.3969/j.issn.1006-1959.2020.23.048]
　LIANG Hong-li.Influence of Omaha System-based Continuous Nursing Model on Behavior Compliance and Calcium and Phosphorus Metabolism of Maintenance Hemodialysis Patients[J].Medical Information,2020,33(23):164.[doi:10.3969/j.issn.1006-1959.2020.23.048]

更新日期/Last Update: 1900-01-01